BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma (Q57744383)

12

object named as

Brigitte Bressac-de Paillerets

0 references

author name string

Christian Monnerat

1

0 references

Agnès Chompret

2

0 references

Caroline Kannengiesser

3

0 references

Marie-Françoise Avril

4

0 references

Nicolas Janin

5

0 references

Alain Spatz

6

0 references

Jean-Marc Guinebretière

7

0 references

Catalin Marian

8

0 references

Michel Barrois

9

0 references

Françoise Boitier

10

0 references

Gilbert M. Lenoir

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden

11

0 references

publication date

12 July 2007

0 references

published in

Familial Cancer

0 references

volume

6

0 references

issue

4

0 references

page(s)

453-461

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10689-007-9143-Y

Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-007-9143-Y

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-007-9143-Y

Geographical variation in the penetrance of CDKN2A mutations for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-007-9143-Y

BRCA2 T2722R is a deleterious allele that causes exon skipping

21 January 2018

1 reference

12 December 2020

De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation

1 reference

12 December 2020

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype

1 reference

12 December 2020

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

1 reference

12 December 2020

Multiple primary tumours in patients treated with radiotherapy for breast cancer

1 reference

12 December 2020

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

1 reference

12 December 2020

Incidence of invasive cancers following cutaneous malignant melanoma

1 reference

12 December 2020

The BRC repeats are conserved in mammalian BRCA2 proteins

1 reference

12 December 2020

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

1 reference

12 December 2020

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

1 reference

12 December 2020

Increased risk of second cancers following breast cancer: role of the initial treatment

1 reference

12 December 2020

A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2

1 reference

12 December 2020

Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma

1 reference

12 December 2020

BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease

1 reference

12 December 2020

Functional evaluation and cancer risk assessment of BRCA2 unclassified variants

1 reference

12 December 2020

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium

1 reference

12 December 2020

Are malignant melanoma patients at higher risk for a second cancer?

1 reference

12 December 2020

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

12 December 2020

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

1 reference

12 December 2020

Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution

1 reference

12 December 2020

Coincident PTCH and BRCA1 germline mutations in a patient with nevoid basal cell carcinoma syndrome and familial breast cancer

1 reference

12 December 2020

Melanoma and additional primary cancers

1 reference

12 December 2020

Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

1 reference

12 December 2020

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

12 December 2020

Second cancer following cancer of the breast in Connecticut, 1935-82

1 reference

12 December 2020

Identification of the breast cancer susceptibility gene BRCA2

1 reference

12 December 2020

Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989.

1 reference

12 December 2020

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee

1 reference

12 December 2020

Germline p16 mutations in familial melanoma

1 reference

12 December 2020

Denaturing high-performance liquid chromatography: A review

1 reference

12 December 2020

Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer.

1 reference

12 December 2020

Second cancer following cancer of the female breast in Denmark, 1943-80.

1 reference

12 December 2020

P53 germline mutations in childhood cancers and cancer risk for carrier individuals

1 reference

12 December 2020

A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees.

1 reference

12 December 2020

Will the real Cowden syndrome please stand up: revised diagnostic criteria

1 reference

12 December 2020

Racial and age differences in multiple primary cancers after breast cancer: a population-based analysis

1 reference

12 December 2020

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia

1 reference

12 December 2020

Association between female breast cancer and cutaneous melanoma

1 reference

12 December 2020

Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast

1 reference

12 December 2020

Risk of second cancer among women with breast cancer

1 reference

12 December 2020

An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2.

1 reference

12 December 2020

Second primary cancers in breast cancer patients in Slovenia

1 reference

12 December 2020